![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Assessment of Safety and Efficacy of Abacavir/Lamivudine and Tenofovir/Emtricitabine in Treatment-Naïve HIV-1 Infected Subjects
ASSERT: 48-Week Result
|
|
|
Reported by Jules Levin
EACS November 13 2009, Cologne, Germany
HJ Stellbrink, G Moyle, C Orkin, J Arribas, H Pearce, P Zucchi for the ASSERT Team
Study Sponsored by GSK
![image002.gif](../images/111509/110509-1/image002.gif)
![image004.gif](../images/111509/110509-1/image004.gif)
![image006.gif](../images/111509/110509-1/image006.gif)
![image008.gif](../images/111509/110509-1/image008.gif)
![image010.gif](../images/111509/110509-1/image010.gif)
![image012.gif](../images/111509/110509-1/image012.gif)
![image014.gif](../images/111509/110509-1/image014.gif)
![image016.gif](../images/111509/110509-1/image016.gif)
![image018.gif](../images/111509/110509-1/image018.gif)
![image020.gif](../images/111509/110509-1/image020.gif)
![image022.gif](../images/111509/110509-1/image022.gif)
![image024.gif](../images/111509/110509-1/image024.gif)
![image026.gif](../images/111509/110509-1/image026.gif)
![image028.gif](../images/111509/110509-1/image028.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|